Teva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day. We offer a uniquely diverse portfolio of products and solutions for patients and we've built a promising pipeline centered around our core therapeutic areas. We are continually developing patient-centric solutions and significantly growing both our generic and specialty medicines business through investment in research and development, marketing, business development and innovation. This is how we improve health and enable people to live better, healthier lives. Join us on our journey of growth!
The Director, GHEOR position functions within the Global HEOR group and will serve as the principal technical and strategic lead for one or more assets in the neuropsychology therapy area. The position will report to the Senior Director, Late Stage Global HEOR. The incumbent will have one direct report to formally manage.
In accordance with Teva's regulatory and governance requirements, develop and implement peri and post launch comprehensive evidence generation plans, including clinical, economic, and humanistic evidence that inform and contribute to the overall program strategies for one or more assets in the neuropsychology therapy area.
Working closely with the development HEOR counterpart, formulate and update the recommended GHEOR strategies, including the update of the global value proposition and the adaptation, and training of relevant colleagues on indirect comparisons, cost-effectiveness and budget impact models, and value dossiers.
Incorporate, where possible, regional post-launch evidence needs by acting as a liaison between individual market colleagues and GHEOR, and other global functions, e.g. brand teams, medical and EU/US market access.
Working closely with relevant market-specific colleagues, lead and execute HTA submissions (including value framework reports or other HEOR relevant deliverables) to appropriately support asset launch(es).
Provide guidance and input on Phase 3b/4 studies and post-hoc analyses, and post-launch (RWE) study design from a GHEOR perspective and ensure inclusion of appropriate PRO and health economic endpoints into these, as necessary, to maximize asset value proposition in collaboration with medical affairs and commercial colleagues. These studies may include longitudinal prospective observational studies, registries, retrospective database analyses, patient/HCP/caregiver surveys, etc.
Contribute to the payer value and brand team(s) on specific ways in which the evidence generation plan may be improved and optimized to facilitate informed decision making including comparative effectiveness, pricing, reimbursement and market access negotiations, in compliance with regional regulations for use in promotional material.
Represent Teva before relevant scientific, medical, regulatory, payer, patient and other meetings, when appropriate, with some/minimal oversight by the Sr. Director, Late Stage GHEOR.
Explore, request approval for, and implement new concepts that are complex, taking appropriate risks to advance innovative processes and methodologies based on comprehensive business knowledge, e.g. value-based contracts, employer research, etc.
Keep abreast of the trends in the assigned therapeutic area, HEOR, Pricing, Reimbursement, and Market Access across key regions (US, EU, and international markets), and proactively address GHEOR strategy changes in collaboration with global and regional teams in anticipation of these trends.
Build a network of clinical, HEOR and payer experts, including academics, policy makers, HTA representatives, reimbursement influencers and other decision-makers globally to increase the robustness of post-marketing scientific studies in support of market access strategies.
Manage project budgets and timelines in adherence with Teva compliance requirements. To this end, regularly prepare and update summaries reflecting ongoing or completed deliverables.
PhD in Health Economics, Epidemiology, Health Services Research or a related field with at least 7 years of relevant pharmaceutical/biotechnology/academic/governmental agency experience OR a Master's degree in Health Economics, Epidemiology, or related field, and at least 10 years of such relevant experience. A pharmacy/clinical/scientific background is preferred.
A track record of peer-reviewed scientific publications demonstrating expertise in GHEOR
Comprehensive knowledge of own core discipline and good working knowledge of health care systems and health technology assessment guidelines and processes in relevant countries.
Ability to understand disease space and appropriately plan and deliver GHEOR strategy and studies for specific assets. Serve as source of expertise/advice in epidemiology, outcomes research, health economics, health policy for cross-functional team members.
Demonstrate commercial/market access acumen.
High degree of comfort with ambiguity and change.
Ability to anticipate issues/needs and works proactively to address them.
Demonstrate distinctive problem solving and analytical skills.
Have a solution driven approach in resolving complex problems.
Takes initiative, works proactively, with good project management skills and an ability to multi-task and meet tight timelines.
Self -starter, with an ability to work independently or as part of a global team.
Show business maturity, have strong presence and possess advanced written and verbal communication skills.
Exhibits strong collaboration skills and ability to engage across multiple functions and regions.
Ability to manage consensus at various levels and cultivate strategic internal relationships across the organization.
Strategic thinker with strong execution capabilities.
Ability to influence and negotiate without formal direct authority, consultative in approach, and diplomatic
Some national/international travel may be required.
Experience in application of HEOR strategies and tactics for products near to or close to launch, or that are marketed.
Experience in Neuropsychiatry would be a plus.
Experience with global HTA submissions and/or value frameworks is preferred.
Prior direct report management experience
In process of validation
Teva's Equal Employment Opportunity Commitment
Teva Pharmaceuticals is committed to equal opportunity in employment. It is Teva's global policy that equal employment opportunity be provided without regard to age, race, creed, color, religion, sex, disability, pregnancy, medical condition, sexual orientation, gender identity or expression, ancestry, national or ethnic origin or any other legally recognized status entitled to protection under applicable laws.
Nearest Major Market: New York City
Nearest Secondary Market: Newark
Teva Pharmaceutical Industries